243 related articles for article (PubMed ID: 24565956)
1. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
[TBL] [Abstract][Full Text] [Related]
2. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
Chan AT; Ogino S; Giovannucci EL; Fuchs CS
Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
5. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
Khalaf N; Yuan C; Hamada T; Cao Y; Babic A; Morales-Oyarvide V; Kraft P; Ng K; Giovannucci E; Ogino S; Stampfer M; Cochrane BB; Manson JE; Clish CB; Chan AT; Fuchs CS; Wolpin BM
Gastroenterology; 2018 Apr; 154(5):1380-1390.e5. PubMed ID: 29229401
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.
Stürmer T; Buring JE; Lee IM; Kurth T; Gaziano JM; Glynn RJ
Am J Med; 2006 Jun; 119(6):494-502. PubMed ID: 16750963
[TBL] [Abstract][Full Text] [Related]
7. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
9. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
[TBL] [Abstract][Full Text] [Related]
10. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
11. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
12. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.
Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265
[TBL] [Abstract][Full Text] [Related]
13. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
[TBL] [Abstract][Full Text] [Related]
14. Aspirin use and survival after diagnosis of colorectal cancer.
Chan AT; Ogino S; Fuchs CS
JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
[TBL] [Abstract][Full Text] [Related]
15. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy.
Venè R; Costa D; Augugliaro R; Carlone S; Scabini S; Casoni Pattacini G; Boggio M; Zupo S; Grillo F; Mastracci L; Pitto F; Minghelli S; Ferrari N; Tosetti F; Romairone E; Mingari MC; Poggi A; Benelli R
Cells; 2020 Mar; 9(3):. PubMed ID: 32168749
[TBL] [Abstract][Full Text] [Related]
18. Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?
Brown DA; Hance KW; Rogers CJ; Sansbury LB; Albert PS; Murphy G; Laiyemo AO; Wang Z; Cross AJ; Schatzkin A; Danta M; Srasuebkul P; Amin J; Law M; Breit SN; Lanza E
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):337-46. PubMed ID: 22144502
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
[TBL] [Abstract][Full Text] [Related]
20. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]